JC
Joab Camarena
Also known as: J Camarena
NewYork–Presbyterian Hospital, Stanford University, Stanford University School of Medicine
Research areas: Biochemistry, Genetics and Molecular Biology · Molecular Biology · CRISPR and Genetic Engineering · Virus-based gene therapy research · Hemoglobinopathies and Related Disorders
Employment
-
NewYork–Presbyterian Hospital Pediatric Resident Physician | Physician Scientist Training Program (PSTP)2025 - Present
-
Stanford University School of Medicine Life Research Associate2016 - 2025
Education
-
Stanford University School of Medicine Doctor of Medicine (MD)2019 - 2025
-
Stanford University Biology Honors2012 - 2016
Projects & Funding
Projects & funding information is unavailable.
Publications (22)
- Secreted Particle Information Transfer (SPIT) – A Cellular Platform for In Vivo Genetic Engineering Save
- Enhancement of erythropoietic output by Cas9-mediated insertion of a natural variant in haematopoietic stem and progenitor cells Save
- Demographic and socioeconomic disparities in receipt of ophthalmology consultation for facial trauma Save
- Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease Save
- Gene replacement of α-globin with β-globin restores hemoglobin balance in β-thalassemia-derived hematopoietic stem and progenitor cells Save
- Cas9-AAV6 gene correction of beta-globin in autologous HSCs improves sickle cell disease erythropoiesis in mice Save
- The TRACE-Seq method tracks recombination alleles and identifies clonal reconstitution dynamics of gene targeted human hematopoietic stem cells Save
- Cas9-AAV6-engineered human mesenchymal stromal cells improved cutaneous wound healing in diabetic mice Save
- Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease. Save
- CRISPR/Cas9 Genome Engineering in Engraftable Human Brain-Derived Neural Stem Cells Save
- Identification of preexisting adaptive immunity to Cas9 proteins in humans Save
- Selection-free, high frequency genome editing by homologous recombination of human pluripotent stem cells using Cas9 RNP and AAV6 Save
- A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells Save
- Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34+ Hematopoietic Stem and Progenitor Cells Save
- Priming Human Repopulating Hematopoietic Stem and Progenitor Cells for Cas9/sgRNA Gene Targeting Save
- 39. FACS-Based Enrichment of a Highly Purified HBB-Targeted Hematopoietic Stem and Progenitor Cell Population Using rAAV6 and CRISPR/Cas9 Save
- 43. CRISPR/Cas9 and rAAV6-Mediated Targeted Integration at the CCR5 Locus in Hematopoietic Stem and Progenitor Cells Save
- CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells Save
- Barcoded Clonal Tracking of Gene Targeting in Cells Save
- Differential Proliferation of Human Hematopoietic Stem and Progenitor Cells Using Truncated Erythropoietin Receptors Save